• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EPIC; CALCULATOR/DATA PROCESSING MODULE, FOR CLINICAL USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EPIC; CALCULATOR/DATA PROCESSING MODULE, FOR CLINICAL USE Back to Search Results
Device Problem Application Program Problem: Medication Error (3198)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Event Description
Upon migration of medications to new ehr (eclinical works to epic), a patient had amlodipine/benazepril that was transferred over as amlodipine/atorvastatin.Patient was already on atorvastatin separately and ended up having a medication duplication within their chart.This was caught upon medication reconciliation.Education of staff to verify medication names and combination products were correct before implementation; changes to layout to show full name of medications for verification.Communication, poor / lacking (nonspecific) generic names look alike generic names look alike communication, poor / lacking (nonspecific).Special code: health info technology health info technology.Severity: error occurred; medication did not reach pt.(b)(6).Submission id: (b)(4).
 
Event Description
Additional information received for mw5104512 on 1/14/2022: manufacturer unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EPIC
Type of Device
CALCULATOR/DATA PROCESSING MODULE, FOR CLINICAL USE
MDR Report Key12615351
MDR Text Key276395240
Report NumberMW5104512
Device Sequence Number1
Product Code JQP
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 10/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received10/11/2021
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received01/20/2022
Patient Sequence Number1
Treatment
AMLODIPINE / ATORVASTATIN ; AMLODIPINE / BENAZEPRIL
-
-